Michael Regnier
Corporate Officer/Principal bei University of Washington
Profil
Michael Regnier was the founder of BEAT BioTherapeutics Corp., where he held the title of Director in 2008.
He currently holds the position of Vice Chairman-Bioengineering Department at the University of Washington.
Dr. Regnier earned a doctorate degree from the University of Southern California.
Aktive Positionen von Michael Regnier
| Unternehmen | Position | Beginn |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Regnier
| Unternehmen | Position | Ende |
|---|---|---|
BEAT BioTherapeutics Corp.
 BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Gründer | - |
Ausbildung von Michael Regnier
| University of Southern California | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Health Technology |
